Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More
The plant milking technology is capable of producing high value active pharmaceutical compounds More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More
Long standing experienced South American Laboratory is seeking to expand its distribution of prescription products into Nigeria, Kenya and Angola. More
A vector to be used for transfection and purification of human soluble FcRn receptor More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2008 - 120 pages - $1,040
Apr 2010 - 510 pages - $2,695
Nov 2011 - 7 pages - $3,835
Jan 2009 - $15,200
Nov 2010 - 40 pages - $500
May 2011 - 5 pages - $500
May 2011 - 43 pages - $500
Sep 2010 - 412 pages - $1,040
Nov 2010 - 7 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Acute coronary syndromes
- Anemia
- Anticoagulants
- Blood clotting
- Blood composition
- Cardiovascular disorder (other)
- Cerebrovascular disorders
- Thrombotic disorders
- Treatments
- Vascular
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us